1,2-distearoylphosphatidylethanolamine and Bone Cancer

1,2-distearoylphosphatidylethanolamine has been researched along with Bone Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, Y; Cui, H; Liu, DZ; Liu, M; Mei, QB; Ye, WL; Zhang, BL; Zhao, YP; Zhou, SY	1

Other Studies

1 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Bone Cancer

Article	Year
Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption. Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup1 Topics: A549 Cells; Animals; Bone Neoplasms; Bone Resorption; Cell Proliferation; Doxorubicin; Female; Humans; Hydrophobic and Hydrophilic Interactions; Lung Neoplasms; Mice; Mice, Nude; Micelles; Molecular Targeted Therapy; Oxidation-Reduction; Phosphatidylethanolamines; Tissue Distribution	2018

Article

Year

Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption.

Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup1

Topics: A549 Cells; Animals; Bone Neoplasms; Bone Resorption; Cell Proliferation; Doxorubicin; Female; Humans; Hydrophobic and Hydrophilic Interactions; Lung Neoplasms; Mice; Mice, Nude; Micelles; Molecular Targeted Therapy; Oxidation-Reduction; Phosphatidylethanolamines; Tissue Distribution

2018